17 articles for JJ Marugan
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery, optimization, and characterization of novel D2 dopamine receptor selective antagonists.
National Center For Advancing Translational Sciences
Structure-activity relationship of imidazopyridinium analogues as antagonists of neuropeptide s receptor.
National Institutes of Health
Non-peptidic alpha(v)beta3 antagonists containing indol-1-yl propionic acids.
Johnson & Johnson Pharmaceutical Research and Development
Discovery of a novel noniminosugar acida glucosidase chaperone series.
National Center For Advancing Translational Sciences
Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase.
National Center For Advancing Translation Sciences
Design, synthesis, and biochemical evaluation of novel alpha V beta 3 integrin ligands.
3-Dimensional Pharmaceuticals
Discovery, synthesis, and biological evaluation of novel SMN protein modulators.
National Human Genome Research Institute
Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk).
National Human Genome Research Institute
Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis.
University of Kansas
Structure-Based Optimization of Small Molecule Human Galactokinase Inhibitors.
National Center For Advancing Translational Sciences
Non-iminosugar glucocerebrosidase small molecule chaperones.
National Human Genome Research Institute
Optimization of the first small-molecule relaxin/insulin-like family peptide receptor (RXFP1) agonists: Activation results in an antifibrotic gene expression profile.
National Center For Advancing Translational Sciences
Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication Cycle.
National Institute of Diabetes and Digestive and Kidney Diseases
2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease
Lycera
Aromatic heterocyclic compounds and their application in pharmaceuticals
Sunshine Lake Pharma